Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab Phase 2 Trial in Japan (jRCT2080222992)
jRCT2080222992Phase 2Completed
- Start
- Oct 2015
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of pembrolizumab. Started Oct 2015; status: completed.
02
Drugs
Beyond the preview
Go deeper on jRCT2080222992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222992.